Apex Medical Corp, a $75-million company in Taiwan is initially investing 100 crore in Indian healthcare market which the company believes it is the right time to invest in India. The reason for choosing India as its first country was given by Daniel Lee, CEO, Apex Medcial Corp who said “Why we chose India as the first country in South Asia for our foray is because it has a huge population and a new government that is willing to make a big change.” 100 per cent FDI for Medical Devices proves the willing to change.

READ ALSO: Why Invest in India?,  Assessment of Indian Market.

The Indian Healthcare Market is growing at 12 – 15 per cent a year and the Make in India campaign by the new government under Prime Minister Narendra Modi is catching the eye of all medical manufacturers so as Apex Medical Corp. They will market quality and affordable equipment and launch their products in the field of respiratory therapy, such as asthma and sleep apnea and said they were excited about the Indian market.

READ ALSO: Stunning First Visit PM Modi in the US: What it means to the Life Science Sector

Regarding the company’s plans to manufacture in India, Daniel said, “we will start to initially bring from Taiwan and once we know how Make in India takes off we will make it here”. “On research and development we are investing 5 per cent of annual revenue and the products are distributed to US, Europe and other markets through subsidiaries and partners.” he added.

The Hindu Business Line

Other News

Indian Govt Notifies New Norms to Regulate Medical Devices

On February 2, 2017 The Ministry of Health and Family Welfare has announced Medical Devices Rules, 2017 that separates regulatory norms for manufacturing medical devices from drugs. The rules will come into effect from January […]

Read More

Maharashtra FDA Asks Blood Banks to Submit License Renewal Applications

Maharashtra Food and Drug Administration (FDA) has directed all 306 blood banks in the state to submit applications of renewal of licenses by 31st December 2016 to carry out timely inspections and approvals. There are […]

Read More

Indian Syringe and Needle Market 2015-2020

Indian syringes and needles market is expected to grow at a CAGR of 15% by 2020. This growth is mainly because of India’s large pool of patients, increase in healthcare expenditure, increase in healthcare awareness […]

Read More

FSSAI Drafts Safety Regulations for Nutraceuticals & Food Supplements

The Ministry of Health’s Food Safety Standards Authority of India has come out with quality and safety standards to regulate the standards and quality of health supplements, nutraceuticals, food (special dietary care, medicinal purpose, functional […]

Read More

FSSAI Proposes New Rules for Health Supplement misabelling

On Monday, Indian food safety watchdog the Food Safety and Standards Authority of India (FSSAI) announced that health supplements cannot be sold as medicines at all and also fixed the permissible limits of various ingredients […]

Read More

More Than Half of Women Plan to Buy Natural Beauty Products

Now a new survey shows that, natural products continue to remain top of mind for many women when it comes to the personal care beauty products. The second annual Green Beauty Barometer survey questioned more […]

Read More

Korean Entrepreneurs to Venture into Indian Cosmetics Market

The United States remains the biggest market for Korean cosmetic products and nowadays Korean investors are venturing into Indian cosmetic market. The Korea Trade Investment Promotion Agency (KOTRA) launched at least 10 Korean cosmetics brands […]

Read More

Meet Us at The Medical Device Regulatory Summit in Mumbai

The first Medical Device Regulatory Summit in India is being held at Holiday Inn Mumbai International Airport on 29 November 2016. Morulaa HealthTech is pleased to partner at this event. Medical Device Regulatory Summit 2016, […]

Read More